274. This Month in Medtech: Edwards’ Big Move, $200M Robotics Bet & AI Shifts

Episode breakdown:00:00 – Intro: Why April Was a Pivotal Month for Medtech01:52 – Supira Medical Raises $120M for pVAD Innovation05:34 – CMR Surgical’s $200M Robotics Bet09:12 – Edwards Lifesciences Gets CE Mark for Sapien M313:01 – Biolinq’s $100M Needle-Free Glucose Monitor15:27 – AI + Imaging: Anumana and Conavi Raise Big18:40 – The Numbers: 3 Fastest-Growing Procedure Segments21:45 – The APAC Expansion Opportunity for Medtech24:15 – NAMSA, FDA, and the New Clinical-First Strategy27:00 – Closing Thoughts: What to Watch Going into May Meet me in NYC this May at MD&M East May 20-22! Get a free expo pass and see my keynote on Wednesday May 21st! Click here and use code OMAR25 https://utm.io/uidBRDon’t Let Cybersecurity Risks Delay Your Medical Device Premarket Approval. Check out BlueGoatCyber.comAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/ This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.